Last Modified: October 13, 2002
Conference Dates: December 5-6, 2002
Conference Location: Washington, DC
Sponsoring Group: Imedex
Conference Web Page URL: www.imedex.com/announcements/usgynonc02.htm
Topics Covered: Epithelial Ovarian Cancer, Cervical Cancer, Vulvar Cancer, Endometrial Cancer
Since 1999, this debate-based conference series has won the interest and support of practitioners on a national and international basis. The depth of coverage and rigorous discussion of important topics in gynecologic oncology by world-class experts has resulted in an exciting and interactive educational experience for our attendees
Conference Objectives: After successfully completing this educational program, participants should be able to: Discuss and explain the various options, their advantages and disadvantages, benefits and risks, for the treatment of cervical, vulvar, endometrial and ovarian cancer in selected stages and selected situations.
Who Should Attend: This program is intended for gynecologists, oncologists, radiation therapists, pathologists, and other practitioners involved in the diagnosis and management of gynecological cancers including ovarian, endometrial and cervical cancers. No specific knowledge or skills other than a basic training in one of the above-mentioned disciplines is required for successful participation in the program.
Registration Information: Register online at www.imedex.com, by phone to 770-751-7332, fax to 770-751-7334.
Conference Fees: Registration fees: Physicians Discounted (registered by 10/25/02)$195, Regular (registered by 11/27/02) $295, On-Site $425, Residents, Students* $99
Continuing Education: Yes
Miscellany: 12 hours CME category 1, AMA-PRA
Feb 20, 2012 - In the United States, the use of partial nephrectomy procedures to manage renal masses in patients with renal cell carcinoma increased significantly from 2002 to 2008, according to research published in the March issue of The Journal of Urology.
Feb 20, 2012
Jul 5, 2010
Feb 10, 2015